ArticleFrontiers in surgery2025
The safety and effectiveness of transforaminal lumbar interbody fusion (TLIF) surgery for the treatment of lumbar disc herniation.
Article in Frontiers in surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clinical Study of Ultrasound-Guided Modified Percutaneous Endoscopic Interlaminar Discectomy Combined With Medical Chitosan in Lumbar 4-5 Disc Herniation Treatment.Orthopaedic surgery · 2026Trial
- Comparison of short-term clinical efficacy between percutaneous endoscopic transforaminal discectomy and unilateral biportal endoscopy in the treatment of upper lumbar disc herniation.BMC musculoskeletal disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The purpose of this study is to discuss the safety and effectiveness of transforaminal lumbar interbody fusion (TLIF) for the treatment of lumbar disc herniation. Methods: From August 2018 to December 2021, patients with lumbar disc herniation who received TLIF treatment were included in this study. Clinical data collected during both the preoperative period and the 2-year postoperative follow-up were analyzed. The correlations between preoperative clinical indicators and postoperative functional outcomes were modeled using both univariate regression and multivariable-adjusted analyses. Result: The study population comprised 547 consecutive cases (male: 261, 47.7%; female: 286, 52.3%). Stratified outcome analysis showed 458 patients (83.7%) attained optimal surgical recovery without detectable morbidity, contrasted with 89 cases (16.3%) manifesting postoperative complications. The univariate analysis of postoperative complications found that the recurrence of symptoms was related to body mass index (BMI), preoperative pain time, High-level segment, intraoperative bleeding volume and postoperative visual analog scale (VAS)-back. Postoperative hematoma was related to hypertension and wound drainage. Poor wound healing was related to BMI and Wound drainage volume. However, this study failed to find the related factors of wound infection. After binary logistic analysis of the above single factors, we found that BMI and preoperative pain time were independent risk factors for symptom recurrence, and BMI were independent risk factors for Poor wound healing. Conclusion: Transforaminal lumbar interbody fusion surgery can safely and effectively treat lumbar disc herniation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.